<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: The aim of this study was to determine whether left ventricular (LV) midwall <z:mp ids='MP_0003045'>fibrosis</z:mp>, detected by midwall hyperenhancement (MWHE) on late <z:chebi fb="0" ids="33375">gadolinium</z:chebi> enhancement cardiovascular magnetic resonance (CMR) imaging, predicts mortality and morbidity in patients with <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> (<z:chebi fb="20" ids="15767">DCM</z:chebi>) undergoing cardiac resynchronization therapy (CRT) </plain></SENT>
<SENT sid="1" pm="."><plain>BACKGROUND: Midwall <z:mp ids='MP_0003045'>fibrosis</z:mp> predicts mortality and morbidity in patients with <z:chebi fb="20" ids="15767">DCM</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Patients with <z:chebi fb="20" ids="15767">DCM</z:chebi> with (+) or without (-) MWHE (n = 20 and n = 77, respectively) as well as 161 patients with ischemic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> (ICM) undergoing CRT (n = 258) were followed up for a maximum of 8.7 years </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Among patients with <z:chebi fb="20" ids="15767">DCM</z:chebi>, +MWHE predicted cardiovascular mortality (hazard ratio [HR]: 18.6; 95% confidence intervals [CI]: 3.51 to 98.5; p = 0.0008), total mortality or hospitalization for major adverse cardiovascular events (HR: 7.57; 95% CI: 2.71 to 21.2; p &lt; 0.0001), and cardiovascular mortality or <z:hpo ids='HP_0001635'>heart failure</z:hpo> hospitalizations (HR: 9.56; 95% CI: 2.72 to 33.6; p = 0.0004), independent of New York Heart Association class, QRS duration, <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo>, LV volumes, LV ejection fraction, and a CMR-derived measure of dyssynchrony </plain></SENT>
<SENT sid="4" pm="."><plain>Among patients with <z:chebi fb="20" ids="15767">DCM</z:chebi> and ICM, the risk of cardiovascular mortality for <z:chebi fb="20" ids="15767">DCM</z:chebi> +MWHE (adjusted HR: 18.5; 95% CI: 3.93 to 87.3; p = 0.0002) was similar to that for ICM (adjusted HR: 21.0; 95% CI: 5.06 to 87.2; p &lt; 0.0001) </plain></SENT>
<SENT sid="5" pm="."><plain>Both <z:chebi fb="20" ids="15767">DCM</z:chebi> +MWHE and ICM were predictors of pump failure <z:hpo ids='HP_0011420'>death</z:hpo> as well as <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>LV reverse remodeling was observed in <z:chebi fb="20" ids="15767">DCM</z:chebi> -MWHE and in ICM but not in <z:chebi fb="20" ids="15767">DCM</z:chebi> +MWHE </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Midwall <z:mp ids='MP_0003045'>fibrosis</z:mp> is an independent predictor of mortality and morbidity in patients with <z:chebi fb="20" ids="15767">DCM</z:chebi> undergoing CRT </plain></SENT>
<SENT sid="8" pm="."><plain>The outcome of <z:chebi fb="20" ids="15767">DCM</z:chebi> with midwall <z:mp ids='MP_0003045'>fibrosis</z:mp> is similar to that of ICM </plain></SENT>
<SENT sid="9" pm="."><plain>This relationship is mediated by both pump failure and <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> </plain></SENT>
</text></document>